Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
phenotype | 0.100 | None | 1.000 | 27 | 4 | 1994 | 2020 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.100 | None | 1.000 | 23 | 2 | 1999 | 2020 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 17 | 2 | 2005 | 2020 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 14 | 0 | 2013 | 2019 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 11 | 4 | 2012 | 2019 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.909 | 11 | 0 | 1997 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 0.909 | 11 | 0 | 2004 | 2019 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 10 | 0 | 2000 | 2020 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
phenotype | 0.100 | None | 0.900 | 10 | 2 | 2004 | 2017 | ||||||||
|
neurofascin | 0.682 | 0.423 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
NCK adaptor protein 2 | 0.743 | 0.500 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
phenotype | 0.090 | None | 0.889 | 9 | 5 | 2004 | 2020 | ||||||||
|
hypocretin neuropeptide precursor | 0.500 | 0.808 | 2.9E-02 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2009 | 2020 | ||||||||
|
fatty acid amide hydrolase | 0.545 | 0.692 | 4.4E-11 |
|
phenotype | 0.080 | None | 1.000 | 8 | 1 | 2004 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2015 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
arylsulfatase family member I | 0.656 | 0.615 | 6.0E-15 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2020 | ||||||||
|
sigma non-opioid intracellular receptor 1 | 0.544 | 0.808 | 0.17 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2016 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 2016 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2019 | ||||||||
|
paired like homeodomain 2 | 0.489 | 0.808 | 0.98 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2019 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.050 | None | 1.000 | 5 | 3 | 2004 | 2018 |